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tients between January 2008 and September 2013. Eligible patients
had a primary procedure for an interventional or diagnostic CV
procedure deﬁned by ICD-9 and/or Current Procedural Terminology
(CPT) codes, inpatient admission, and LOCM or iso-osmolar CM
agent. CM agents were identiﬁed by Standard Charge Master codes
and text mining algorithms. One iso-osmolar CM, iodixanol, was
identiﬁed. Six LOCMs were identiﬁed: iohexol, ioversol, iopamidol,
ioxaglate, ioxilan, and iopromide. AKI and CIAKI events were
determined by ICD-9 diagnosis codes. Multivariable regression
analysis was conducted using Ordinary Least Square (OLS) and
hospital ﬁxed-effects speciﬁcations to assess the relationship be-
tween the CM used and CIAKI events for patients with an AKI
event.
RESULTS A total of 385,290 interventional and 277,009 diagnostic
CV procedure visits were identiﬁed. Iso-osmolar CM was used more
in older interventional patients (67.0 vs. 63.8; p<0.0001) and in
older diagnostic patients (66.0 vs. 61.7; p <0.0001) compared to
LOCM. In both populations, patients receiving iso-osmolar CM were
sicker as measured by Charlson Comorbidity Index Score compared
to patients receiving LOCM (3.9 vs. 3.4; p<0.0001, & 3.9 vs. 3.2;
p<0.0001 for interventional and diagnostic, respectively). Of all
patients, 22,925 interventional and 20,635 diagnostic had an AKI.
Within this group, 1,539 interventional and 807 diagnostic patients
had their AKI classiﬁed as a CIAKI. Univariate OLS analysis indi-
cated that patients receiving an iso-osmolar CM had 0.8% (p<0.05)
and 0.2% (p NS) fewer CIAKI events compared to a LOCM for
interventional and diagnostic procedures, respectively. Controlling
for detailed patient characteristics and time-invariant unobserved
heterogeneity across hospitals using hospital ﬁxed-effects resulted
in 1.24% (p < 0.01) and 1.0% (p<0.01) fewer CIAKI events with iso-
osmolar CM for interventional and diagnostic procedures, respec-
tively. These absolute reductions represented 18% and 25% relative
reductions for overall interventional and diagnostic populations,
respectively.
CONCLUSIONS In this retrospective study of patients with a record of
AKI, the use of iso-osmolar CM was associated with fewer CIAKI
events compared to LOCMs for patients undergoing inpatient inter-
ventional or diagnostic CV procedures.
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BACKGROUND Chronic kidney disease (CKD) and diabetes mellitus
(DM) are associated with increased risk of adverse events in pa-
tients with drug eluting stents (DES). Prior studies were con-
ducted on predominantly male patient populations; thus the
effect of CKD and DM on outcomes in women with DES remains
unclear.
METHODS The purpose of this study was to characterize the in-
dependent and combined impact of CKD and DM on outcomes in
women undergoing DES implantation. We pooled patient-level
data from 26 randomized controlled trials of DES. The primary
outcomes of interest were all-cause mortality and major adversecardiac event (MACE) deﬁned as the composite of all-cause mor-
tality, myocardial infarction or stent thrombosis, at 3 years after
DES placement. The study population was stratiﬁed into 4 groups:
women with neither DM nor CKD, those with DM and no CKD,
those with CKD and no DM, and those with both DM and CKD.
Women who received a bare metal stent were excluded from this
analysis.
RESULTS Out of 4210 women in the pooled dataset for whom
baseline creatinine levels were available, 1794 (43.0%) had neither
DM nor CKD, 965 (23.0%) had CKD alone, 972 (23.0%) had DM
alone, and 479 (11.0%) had both DM and CKD. A stepwise increase
in 3-year crude event rates was observed in the transition from
no CKD or DM, DM alone, CKD alone,to both CKD and DM
(Figure 1).Following multivariable adjustment, hazard ratios (HR)
for all-cause mortality were: 1.81 (95% CI: 1.20 – 2.73) in patients
with DM alone, 1.38 (95% CI: 0.93 – 2.07) in patients with CKD
alone, and 3.49 (95% CI: 2.33 – 5.23) in patients with both CKD
and DM (trend p value <0.0001). Conversely, the adjusted HRs for
MACE were 1.24 (95% CI: 0.94-1.64) in patients with DM alone,
1.01 (95% CI: 0.76 – 1.34) in patients with CKD alone, and 2.18
(95% CI: 1.63-2.92) in patients with both CKD and DM (trend
p value<0.0001).CONCLUSIONS The presence of both CKD and DM confers a syner-
gistic adverse effect on the risk for long-term MACE in women un-
dergoing PCI.
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BACKGROUND Contrast-induced acute kidney injury (CIAKI) is a
common complication of coronary catheterization. Although several
strategies have been proposed, the real efﬁcacy in reducing CIAKI
of most of these is debated. We pooled data from randomized
trials comparing different preventive strategies for CIAKI in pa-
tients undergoing coronary catheterization to deﬁne the relative
efﬁcacy.
METHODS Randomized trials comparing 2 different strategies
were searched in major scientiﬁc databases. Trials including pa-
tients undergoing procedures requiring contrast media different
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same drug were not considered. Main CIAKI deﬁnition was a 25%
or 0.5 mg/ml serum creatinine increase from baseline within the
ﬁrst 5 days. Subanalyses according to dissimilar CIAKI deﬁnitions
were planned. A hierarchical Bayesian network meta-analysis was
performed using a random effects consistency model computed by
Markov Chain Monte Carlo methods with Gibbs sampling based on
100,000 iterations following discard of 50,000 “burn-in” iterations.
Posterior inference was expressed as odds ratio (OR) and 95%
credibility interval (CrI).
RESULTS A total of 138 trials (31,720 patients) and 35 different
strategies were identiﬁed. Most of these treatments, however, were
deriving from few small trials. Considering the pooled incidence of
CIAKI in the Saline/Placebo group, we estimated that 600 patients
were required to reduce by 50% this rate. Imposing this study size
ﬁlter a total of 93 trials (27,781 patients) and 6 different strategies
(Saline/Placebo, Statin, N-Acetylcysteine [NAC], HCO3 [Bicarbon-
ate], NAC+HCO3, Ascorbic Acid) were identiﬁed. Statin was the
most effective strategy, leading to a signiﬁcant 60% risk reduction
compared with Saline/Placebo, followed by HCO3. Although
NAC was the less effective treatment, it was associated with a
signiﬁcant 30% risk reduction compared with Saline/Placebo.
The difference between NAC+HCO3 or Ascorbic Acid and Saline/
Placebo was not signiﬁcant. The network node-split showed
inconsistency only for NAC+HCO3 vs Saline/Placebo and there was
coherence between direct and indirect evidence for all the others
comparisons.CONCLUSIONS Statin was the most effective preventive strategy for
CIAKI, followed by HCO3. Although NAC was the less effective treat-
ment, it seemed to produce a mild CIAKI risk reduction.
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BACKGROUND Impaired renal function is associated with adverse
clinical outcome in patient with acute myocardial infarction (AMI).
However, few data exist on the association of worsening renal func-
tion and long-term mortality in patients who survived at 1 year after
index AMI.
METHODS We consecutively enrolled AMI patients who underwent
percutaneous coronary intervention (PCI) between January 2004
and December 2009 from nine university hospitals throughout
South Korea. Patients who were alive and did not experience a
recurrent MI or stroke during the ﬁrst 365 days post-index MI
were analyzed in this study. We excluded 169 patients with esti-
mated glomerular ﬁltration rate (eGFR) below 15 ml/min/m2. We
divided patients to quintiles according to the degree of changes in
the eGFR value between index AMI and 1 year later. The
primary endpoint was all-cause mortality from Day 366 to study
completion.
RESULTS of 4.748 AMI patients, 1,929 patients were alive and
their GFR values were available for the assessment of all-cause
mortality. The median change of eGFR was -0.7 ml/min/m2. All-
cause mortality from 1 to 4 year of index AMI was 10.6% in the
1st quintile ( 20% decline in eGFR values) and 4.5% in the
remained quintiles [Unadjusted HR (95% CI) 2.38 (1.61-3.50),
p<0.001]. In multivariable Cox proportional regression analysis,
older age [Adjusted HR (95% CI)4.40 (2.69-7.21), p<0.001], not
taking dual antiplatelet agent at 1 year [2.09 (1.40-3.10), p<0.001],
non-ST-segment elevation myocardial infarction at index events
[1.83 (1.24-2.69), p¼0.002], and worsening eGFR within the ﬁrst
year [1.51 (1.01-2.26), p¼0.04] were the predictors of long-term
mortality.
CONCLUSIONS Worsening renal function within the ﬁrst year after
index AMI was associated with long-term mortality in stable post-MI
1-year survivors.
